Ameritas Investment Partners, Inc. Agenus Inc Transaction History

Ameritas Investment Partners, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $10,871 - $18,249	9,707 Added 39.82%	34,082 $38,000
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $8,318 - $13,383	4,118 Added 20.33%	24,375 $58,000
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $6,240 - $12,672	4,800 Added 31.05%	20,257 $39,000
Q2 2021 Aug 06, 2021	BUY	$2.56 - $5.49 $8,263 - $17,721	3,228 Added 26.4%	15,457 $85,000
Q2 2020 Aug 05, 2020	BUY	$2.29 - $4.24 $7,376 - $13,657	3,221 Added 35.76%	12,229 $48,000
Q2 2019 Aug 14, 2019	BUY	$2.53 - $3.04 $8,680 - $10,430	3,431 Added 61.52%	9,008 $27,000
Q2 2017 Aug 15, 2017	BUY	N/A	5,577	5,577 $22,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.